Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Cheche Group Q4 2024 Earnings Narrowed Loss Beats Estimates Despite Stock Decline FFWM Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement FUL Q1 2026 Earnings EPS Beats Estimates as Stock Rises 25 Oxford Industries OXM Q1 2026 Earnings Surprise Loss Meets Optimistic Market Sentiment FHTX Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances